2022 BIO CEO & Investor Conference: Hybrid Event
For more than 20 years, the BIO CEO & Investor Conference has fueled the biotech industry networking with premier investor and banking communities, focused on established and emerging publicly traded and select private biotech companies.
The BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies, where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry.
Engage in Meaningful Discussions and Critical Programming on:
Implications of Biden administration healthcare policy initiatives on biotech
ESG investor expectations as well as IPO, M&A, and SPAC trends
Company Presentations are an integral programming element at BIO CEO & Investor Digital Conference that allow companies to discuss their pipeline, R&D activities, and future fundraising goals to this exclusive audience of investors and collaboration partners.
Subscribe to BIO CEO & Investor Conference and receive timely event updates, exclusive content, partnering and programming announcements, and more.